HomeMedical SpecialtiesOncologyRethinking chemotherapy treatment with patients in mind

Rethinking chemotherapy treatment with patients in mind

Published on

New chemotherapy model improves patient satisfaction

A new Two-Day Chemotherapy Model at Trillium Health Partners (THP) is providing patients with a more personalized treatment plan, leading to higher quality care and a better patient experience.

In early 2014, Cancer Care Ontario recognized THP for achieving the shortest cancer wait times in the province.  Shortly thereafter, the Two-Day Chemotherapy Model was implemented with the goal of reducing wait times even further, improving patient flow and above all, improving patient satisfaction.

Traditionally, patients only had the option of one-day chemotherapy treatment, which meant a patient would have to go through blood tests, oncologist appointments and chemotherapy all in one day. This process meant long days for patients, who often spent lengthy periods of time waiting in between appointments.

MORE: LOOKING FOR ANSWERS TO OVARIAN CANCER

Under the Two-Day Chemotherapy Model, patients have three appointments over two days. On the first day, patients have their blood work done and meet with their oncologist. Based on the results of these appointments, the second day is dedicated to chemotherapy treatment. Patients spend less time waiting for appointments and have more flexibility to schedule their daily lives around their treatment.

Ross has been undergoing chemotherapy treatment at THP for the past two years.

“In my first year of treatment I was on the one-day chemotherapy model. My treatments were four hours long, which made for a very long day,” says Ross.

The two-day model empowers patients to be more involved in their treatment plan by providing them with choices about how and when they receive treatment. Ross says the two-day model suits him much better. “On the two-day model I feel more in control of my treatment. There is more certainty. After I get my blood results, I know whether or not I will have chemotherapy the next day,” sa Ross.

Now marking its one-year anniversary, the two-day model has significantly reduced oncology patient wait times for patients on both the one-day and two-day models. Patients on the two-day model saw wait times decrease by 77 minutes for blood work and appointments with their oncologist, and 25 minutes for chemotherapy treatment. Overall, all patients undergoing chemotherapy treatment have seen wait times reduced by nearly 90 minutes.

MORE: NEW PORTABLE XRAY IMPROVES CARE FOR SURGICAL PATIENTS

“Truly patient-centred care requires building programs and treatments around the patient – taking into account patient needs both inside the hospital and beyond its walls,” said Dr. Craig McFadyen, Chief and Medical Director, Trillium Health Partners and Regional Vice-President, Mississauga Halton/Central West Regional Cancer Program. “The two-day model gives patients easy and timely access to high quality care.”

Staff see first-hand the improvements the two-day model has made to the patient treatment plan and flow of the clinic. “The two-day model is a step forward for our clinic,” said Cindy Burzycki a registered nurse in THP’s oncology program. “It is time-saving for the patient and efficient for staff. Nurses are not rushed and can spend quality time with each patient.”

THP is a recognized leader in providing comprehensive world-class cancer care treatment. To continue to deliver exceptional patient care, THP will open a new clinic for cancer patients in 2015 to provide direct access to urgent care for patients requiring follow-up treatment, avoiding visits to the emergency department and admissions to hospital. The new clinic will provide patients with convenient access to the specialists they need without having to wait in the emergency department or be admitted to a hospital bed.

Through compassion, excellence and courage, Trillium Health Partners is paving the way for a new kind of health care within its community and beyond.

Latest articles

The Canadian Consensus Statement on the management of venous leg ulcers

This Consensus Statement was developed with the objective of creating a concise document that...

A pathway to independence for patients with rare disease

Nearly 20 years ago, Audrey Gouskos came through the St. Michael’s Hospital Emergency Department...

Robotic-assisted rehabilitation now available in Fraser Health

Stroke patient Leanne Mork is learning to walk again with the assistance of a...

Helping Canada Design Health Care Facilities for Future Needs

Health care facilities (HCFs) play an important role in communities, providing a safe, secure,...

More like this

Child undernutrition may be contributing to global measles outbreaks, researchers find

Amid a global surge in measles cases, new research suggests that undernutrition may be...

Research suggests link between COVID-19 vaccine hesitancy and increasing uncertainty in routine vaccines for young children

A study published last week, Parental Factors Associated With Measles–Mumps–Rubella Vaccination in US Children Younger...

Are anxiety and depression useful predictors of heart disease risk?

Adding measures of anxiety and depression to a commonly used cardiovascular risk predictor would...

Provinces need to come together now to make pharmacare a reality for all Canadians

With a federal election looming, we need swift action to make pharmacare a reality...

The role of healthcare in mitigating the climate crisis

The role of healthcare in mitigating the climate crisis By Wendy Levinson Canada signed the historic...

New Institute of Urologic Sciences launches in Vancouver

The M. H. Mohseni Institute of Urologic Sciences has officially launched within the Vancouver...